Global Monkeypox Outbreak: Lessons Learned and Future Directions
Year: 2024
Type: article
Abstract: The orthopoxvirus, which causes monkeypox, is a pathogenic viral infection that has become a major global health concern. Monkeypox has lower death and transmission rates than smallpox, despite similarities between them. The 2022 global outbreak highlighted the virus's ability to impact an extensive spectrum of populations, owing to its new strain and its spreading. The epidemiological dynamics, clinical symptoms, diagnostic methods, and preventative measures for monkeypox are examined in this article. Significant results include the introduction of a novel strain of monkeypox, which mostly spreads from male to male, and the effectiveness of smallpox vaccinations in averting illness. The study further emphasizes the value of antiviral medications such as bicidofovir and tecovirimat in the treatment of monkeypox infections. A comprehensive approach including timely vaccination campaigns, better diagnostic methods, more surveillance, and the creation of revolutionary antiviral medications is required to effectively combat monkeypox. In order to contain the spread of this newly discovered infectious disease and avoid further outbreaks, coordination and awareness on a global scale are essential. Double-check Gemini's responses as it may disclose false information, including personal information. Gemini Apps and privacy functions as a new window.
Author: Ankita Singh, Suraj Kumar, Jiten Goray, Shivam Kashyap, Gangadhar Singh, Sudarshan Rawani, Priyanshu Kumar Singh, Ayush Kumar Verma, Rashmi Kumari, Purnima Kumari, Nisha Kumari, Anisha Kumari, Sweta Verma, Megha Chattaraj, Prince Verma, Arnab Roy*, Dr. K. Rajeswar Dutt
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6949583676
FWCI:
Cites:
Cited by:
Related to: